1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide and Diabetes Mellitus

1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide has been researched along with Diabetes Mellitus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chang, Y; Chen, C; Ye, Y; Yu, T; Yu, Z; Zeng, S; Zhan, S; Zheng, X; Zou, X	1

Other Studies

1 other study(ies) available for 1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide and Diabetes Mellitus

Article	Year
Electrophysiological evidence of diabetes' impacts on central conduction recoveries in degenerative cervical myelopathy after surgery. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2023, Volume: 32, Issue:6 Topics: Cervical Vertebrae; Diabetes Mellitus; Humans; Insulins; Spinal Cord Diseases; Treatment Outcome	2023

Article

Year

Electrophysiological evidence of diabetes' impacts on central conduction recoveries in degenerative cervical myelopathy after surgery.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2023, Volume: 32, Issue:6

Topics: Cervical Vertebrae; Diabetes Mellitus; Humans; Insulins; Spinal Cord Diseases; Treatment Outcome

2023